AbbVie

Public ABBV · United States

FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
13 approved
13 in Phase 3
Next date
Mirvetuximab soravtansine, Phase 2 trial completes
Drugs
72
in active trials · 172 in all
Trials
185 active
593 since 2021

Drugs72

DrugHow it worksPartnerStageNext dateDetails
Monoclonal antibody
Approved Nov 2026soonPhase 2 trial completes
Janus kinase inhibitor
Approved Nov 2026soonPhase 3 trial completes
BCL-2 inhibitor
Approved Nov 2026soonPhase 2 trial completes
Atypical antipsychotic
Approved 15 Dec 2026soonPhase 3 trial completes
Monoclonal antibody
Approved Feb 2027Phase 1/2 trial completes
Monoclonal antibody
Approved Mar 2027Phase 3 trial completes
Calcitonin gene-related peptide receptor antagonist
Approved May 2027Phase 3 trial completes
Acetylcholine release Inhibitor; neuromuscular blocker
Approved Jun 2027Phase 4 trial completes
Gonadotropin releasing hormone receptor antagonist
Approved Jul 2027Phase 3 trial completes
Monoclonal antibody
Approved Sep 2027Phase 2 trial completes
C-Met-targeted antibody-drug conjugate
Approved Feb 2028Phase 2 trial completes
Calcitonin gene-related peptide receptor antagonist
Approved Mar 2028Phase 3 trial completes
Mu-Opioid receptor agonist
Approved Dec 2032Phase 3 trial completes
PD-1 antibody
Phase 2/3 Nov 2026soonPhase 2 trial completes
GARP/TGF-beta antibody
Phase 2/3 Nov 2026soonPhase 2 trial completes
Monoclonal antibody
Phase 3 Dec 2026Phase 3 trial completes
—
Phase 3 31 Dec 2026Phase 1 trial completes
Gene therapy substances
Phase 3 Dec 2026Phase 2/3 trial completes
Monoclonal antibody
Phase 3 Dec 2026Phase 2 trial completes
PD-1/VEGF bispecific antibody
RemeGen
Phase 3 12 May 2027Phase 2/3 trial completes

See all 72 drugs

Sign in free to see the whole list. No card, no password.

Sign in free

SEC filings54

Since Jan 2024 · All on SEC.gov

About

No active trial
100 other drugs
Registry names
3 names in ClinicalTrials.gov
Sources
ClinicalTrials.gov updated 16 Nov 2026 · SEC filings Industry-sponsored drug trials since 2021 · Logos provided by Logo.dev

Follow AbbVie

Following is part of Solo: you see every change to AbbVie the day it happens.

Solo

$49a month

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in